Cargando…

Electrocardiographic parameters and prognosis of renal light chain amyloidosis

BACKGROUND: Cardiac involvement frequently occurs in patients with renal light chain (AL) amyloidosis, which predisposes these patients to heart failure, arrhythmia, or infarction with poor prognosis. HYPOTHESIS: Twelve‐lead electrocardiogram (ECG) parameters may be associated with prognosis in rena...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Huixian, Wang, Ying, Lan, Ping, Xie, Liyi, Zhao, Yanhong, Lu, Wanhong, Li, Guoliang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wiley Periodicals, Inc. 2020
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534015/ https://www.ncbi.nlm.nih.gov/pubmed/33460229 http://dx.doi.org/10.1002/clc.23426

Ejemplares similares

Associations of Electrocardiographic Parameters with Left Ventricular Longitudinal Strain and Prognosis in Cardiac Light Chain Amyloidosis
por: Kim, Darae, et al.
Publicado: (2019)

Multiorgan involvement by amyloid light chain amyloidosis
por: Li, Guoliang, et al.
Publicado: (2019)

Electrocardiographic findings in peripartum cardiomyopathy
por: Honigberg, Michael C., et al.
Publicado: (2019)

Electrocardiographic modifications induced by breast implants
por: Bun, Sok‐Sithikun, et al.
Publicado: (2019)

T1 mapping and survival in systemic light-chain amyloidosis
por: Banypersad, Sanjay M., et al.
Publicado: (2015)

Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2018)

Raccoon Eye Sign in Amyloid Light-chain Amyloidosis
por: Mizuno, Shinichi
Publicado: (2022)

Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment
por: Martinez-Naharro, Ana, et al.
Publicado: (2022)

Electrocardiographic characteristics of cirrhotic patients and their association with Child‐Pugh score
por: Jahangiri, Soodeh, et al.
Publicado: (2023)

Association of obesity phenotypes with electrocardiographic subclinical myocardial injury in the general population
por: Vasim, Izzah, et al.
Publicado: (2019)

Optimized electrocardiographic criteria for the detection of left ventricular hypertrophy in obesity patients
por: Snelder, Sanne M., et al.
Publicado: (2020)

Analysis of the Expression of Exostosins and Clinicopathological Features in Membranous Lupus Nephritis in a Chinese Cohort
por: Li, Huixian, et al.
Publicado: (2022)

Light-Chain Amyloidosis With Peripheral Neuropathy as an Initial Presentation
por: Qian, Min, et al.
Publicado: (2021)

Evidence of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis in 2 Patients
por: Donnelly, Joseph P., et al.
Publicado: (2020)

Prognostic value of admission electrocardiographic findings in non‐ST‐segment elevation myocardial infarction
por: Chen, Peng‐fei, et al.
Publicado: (2020)

Novel Therapies in Light Chain Amyloidosis
por: Milani, Paolo, et al.
Publicado: (2017)

DUAL expectations in light chain amyloidosis
por: Schönland, Stefan, et al.
Publicado: (2020)

A real-world study on diagnosis and prognosis of light-chain cardiac amyloidosis in Southern China
por: Wu, Zhijian, et al.
Publicado: (2021)

Primary Light-chain Amyloidosis Featuring Worm-like Small Bowel Polyposis
por: Nishimura, Naoyuki, et al.
Publicado: (2017)

Evaluation of left ventricular myocardial deformation parameters in individuals with electrocardiographic early repolarization pattern
por: Gülel, Okan, et al.
Publicado: (2016)

Simultaneous Clinical Presentation of Renal Cell Carcinoma and Immunoglobulin Light Chain Amyloidosis
por: Prasad, Bhanu, et al.
Publicado: (2018)

Waldenström macroglobulinemia presenting as nephrotic syndrome: Renal heavy and light chain amyloidosis
por: Kwakernaak, Arjan J., et al.
Publicado: (2022)

Electrocardiographic Parameters as Predictors of Response to Cardiac Resynchronization Therapy
por: Poposka, Lidija, et al.
Publicado: (2018)

Plasma Hepatocyte Growth Factor for Diagnosis and Prognosis in Light Chain and Transthyretin Cardiac Amyloidosis
por: Zhang, Kathleen W., et al.
Publicado: (2020)

Phase 2 trial of ixazomib, cyclophosphamide, and dexamethasone for previously untreated light chain amyloidosis
por: Muchtar, Eli, et al.
Publicado: (2022)

Localized Lymph Node Light Chain Amyloidosis
por: Dhakal, Binod, et al.
Publicado: (2015)

Importance of FISH genetics in light chain amyloidosis
por: Gertz, Morie A., et al.
Publicado: (2017)

Light Chain (AL) Amyloidosis: The Journey to Diagnosis
por: McCausland, Kristen L., et al.
Publicado: (2017)

Kappa light-chain amyloidosis of gastrointestinal tract
por: Hashimoto, Rintaro, et al.
Publicado: (2019)

Localized Lymph Node Light Chain Amyloidosis
por: Yamamoto, Akira, et al.
Publicado: (2020)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
por: Palladini, Giovanni, et al.
Publicado: (2021)

Light chain amyloidosis presenting as retiform purpura
por: Soliman, Yssra S., et al.
Publicado: (2021)

Light chain cardiac amyloidosis in a nonagenarian
por: Takahashi, Koji, et al.
Publicado: (2022)

Light Chain Amyloidosis: Epidemiology, Staging, and Prognostication
por: Baker, Kelty R.
Publicado: (2022)

COVID-19 and Light Chain Amyloidosis: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Global epidemiology of amyloid light-chain amyloidosis
por: Kumar, Nishant, et al.
Publicado: (2022)

Tubular basement membrane amyloid deposition: is it an indicator of renal progression in light chain amyloidosis?
por: Markóth, Csilla, et al.
Publicado: (2023)

A Case of Isolated Renal Light Chain Amyloidosis With Hematuria and Low Complement Levels
por: Javed, Nismat, et al.
Publicado: (2023)

Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium
por: Lousada, Isabelle, et al.
Publicado: (2015)

Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis
por: Ridouani, Fourat, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1eqenf5apjsaonvgouipoou7n2